Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy

Lymphoma is the most common hematopoietic malignancy in dogs and one of the most frequent among all neoplastic diseases in this species. It can occur in several anatomical locations with distinct histological and immunophenotypes. Depending on the host immune response towards the tumor, prognosis in...

Full description

Bibliographic Details
Main Authors: T.D. Munhoz, L.A. Anai, D.M. Fonseca, L.M. Semolin, F.R. Sueiro, M. Tinucci-Costa
Format: Article
Language:English
Published: Universidade Federal de Minas Gerais 2016-02-01
Series:Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352016000100001&lng=en&tlng=en
_version_ 1818131719208828928
author T.D. Munhoz
L.A. Anai
D.M. Fonseca
L.M. Semolin
F.R. Sueiro
M. Tinucci-Costa
author_facet T.D. Munhoz
L.A. Anai
D.M. Fonseca
L.M. Semolin
F.R. Sueiro
M. Tinucci-Costa
author_sort T.D. Munhoz
collection DOAJ
description Lymphoma is the most common hematopoietic malignancy in dogs and one of the most frequent among all neoplastic diseases in this species. It can occur in several anatomical locations with distinct histological and immunophenotypes. Depending on the host immune response towards the tumor, prognosis information could be collected. Because its well established immunosuppressant, antitumor activity, the function of regulatory T cells (Tregs) in canine neoplasias has been investigated. In this study, we sought to quantify, using flow cytometry, the Tregs subpopulation in peripheral blood of healthy dogs (10) and in those diagnosed with type-B (14) and type-T (8) multicentric lymphoma before (at diagnosis) and after the first cycle (5-week) of 19-week Madison-Wisconsin (MW) protocol of chemotherapy. Our results indicated that dogs with lymphoma showed higher percentage of Tregs (18,84±2,56) when compared to healthy dogs (4,70±0,50) (P<0,01). In addition, 5-week chemotherapy treatment reduced the Tregs subpopulation (7,54±1,08) to levels similar to control (4,70±0,50) (P>0,05). There was no difference in Tregs percentage between B-type (17,45±2,77) and T-type (21,27±5,27) lymphoma (P>0,05). With this, we conclude that canine lymphoma increases Tregs in the peripheral blood and the MW protocol of chemotherapy reduces this cell subpopulation to control values.
first_indexed 2024-12-11T08:25:24Z
format Article
id doaj.art-5e5542e074fc43f1b7a960d5dfb4ae2c
institution Directory Open Access Journal
issn 1678-4162
language English
last_indexed 2024-12-11T08:25:24Z
publishDate 2016-02-01
publisher Universidade Federal de Minas Gerais
record_format Article
series Arquivo Brasileiro de Medicina Veterinária e Zootecnia
spelling doaj.art-5e5542e074fc43f1b7a960d5dfb4ae2c2022-12-22T01:14:33ZengUniversidade Federal de Minas GeraisArquivo Brasileiro de Medicina Veterinária e Zootecnia1678-41622016-02-016811910.1590/1678-4162-8237S0102-09352016000100001Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapyT.D. MunhozL.A. AnaiD.M. FonsecaL.M. SemolinF.R. SueiroM. Tinucci-CostaLymphoma is the most common hematopoietic malignancy in dogs and one of the most frequent among all neoplastic diseases in this species. It can occur in several anatomical locations with distinct histological and immunophenotypes. Depending on the host immune response towards the tumor, prognosis information could be collected. Because its well established immunosuppressant, antitumor activity, the function of regulatory T cells (Tregs) in canine neoplasias has been investigated. In this study, we sought to quantify, using flow cytometry, the Tregs subpopulation in peripheral blood of healthy dogs (10) and in those diagnosed with type-B (14) and type-T (8) multicentric lymphoma before (at diagnosis) and after the first cycle (5-week) of 19-week Madison-Wisconsin (MW) protocol of chemotherapy. Our results indicated that dogs with lymphoma showed higher percentage of Tregs (18,84±2,56) when compared to healthy dogs (4,70±0,50) (P<0,01). In addition, 5-week chemotherapy treatment reduced the Tregs subpopulation (7,54±1,08) to levels similar to control (4,70±0,50) (P>0,05). There was no difference in Tregs percentage between B-type (17,45±2,77) and T-type (21,27±5,27) lymphoma (P>0,05). With this, we conclude that canine lymphoma increases Tregs in the peripheral blood and the MW protocol of chemotherapy reduces this cell subpopulation to control values.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352016000100001&lng=en&tlng=encãeslinfoma multicêntricocitometria de fluxocélulas T reguladoras
spellingShingle T.D. Munhoz
L.A. Anai
D.M. Fonseca
L.M. Semolin
F.R. Sueiro
M. Tinucci-Costa
Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
Arquivo Brasileiro de Medicina Veterinária e Zootecnia
cães
linfoma multicêntrico
citometria de fluxo
células T reguladoras
title Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
title_full Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
title_fullStr Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
title_full_unstemmed Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
title_short Regulatory T cells in dogs with multicentric lymphoma: peripheral blood quantification at diagnosis and after initial stage chemotherapy
title_sort regulatory t cells in dogs with multicentric lymphoma peripheral blood quantification at diagnosis and after initial stage chemotherapy
topic cães
linfoma multicêntrico
citometria de fluxo
células T reguladoras
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352016000100001&lng=en&tlng=en
work_keys_str_mv AT tdmunhoz regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy
AT laanai regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy
AT dmfonseca regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy
AT lmsemolin regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy
AT frsueiro regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy
AT mtinuccicosta regulatorytcellsindogswithmulticentriclymphomaperipheralbloodquantificationatdiagnosisandafterinitialstagechemotherapy